Cytokinetics, Incorporated - stock earnings
CYTK Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -136.9 million USD | 1.7 million USD |
| 2023Q3 | -129.4 million USD | 378000 USD |
| 2023Q2 | -128.6 million USD | 867000 USD |
| 2023Q1 | -129.4 million USD | 4.6 million USD |
| 2022Q4 | -131.5 million USD | 2.0 million USD |
| 2022Q3 | -176.2 million USD | 2.5 million USD |
| 2022Q2 | -28.8 million USD | 89.0 million USD |
| 2022Q1 | -101.0 million USD | 1.1 million USD |
| 2021Q4 | -30.6 million USD | 55.6 million USD |
| 2021Q3 | -76.1 million USD | 5.4 million USD |
| 2021Q2 | -61.6 million USD | 2.8 million USD |
| 2021Q1 | -47.1 million USD | 6.5 million USD |
| 2020Q4 | -43.9 million USD | 6.7 million USD |
| 2020Q3 | -3.2 million USD | 41.7 million USD |
| 2020Q2 | -40.8 million USD | 3.6 million USD |
| 2020Q1 | -39.4 million USD | 3.8 million USD |
| 2019Q4 | -30.6 million USD | 5.2 million USD |
| 2019Q3 | -29.6 million USD | 6.1 million USD |
| 2019Q2 | -32.1 million USD | 7.1 million USD |
| 2019Q1 | -29.4 million USD | 8.5 million USD |
| 2018Q4 | -26.5 million USD | 9.4 million USD |
| 2018Q3 | -22.0 million USD | 10.6 million USD |
| 2018Q2 | -27.5 million USD | 6.2 million USD |
| 2018Q1 | -30.3 million USD | 5.3 million USD |
| 2017Q4 | -40.5 million USD | -18000 USD |
| 2017Q3 | -32.4 million USD | 6.2 million USD |
| 2017Q2 | -29.1 million USD | 3.1 million USD |
| 2017Q1 | -25.9 million USD | 4.2 million USD |
| 2016Q4 | 7.2 million USD | 33.1 million USD |
| 2016Q3 | 31.9 million USD | 59.0 million USD |
| 2016Q2 | -11.6 million USD | 5.8 million USD |
| 2016Q1 | -12.5 million USD | 8.4 million USD |
| 2015Q4 | -9.2 million USD | 9.8 million USD |
| 2015Q3 | -8.8 million USD | 7.9 million USD |
| 2015Q2 | -10.6 million USD | 6.5 million USD |
| 2015Q1 | -8.9 million USD | 4.4 million USD |
| 2014Q4 | 8.4 million USD | 21.8 million USD |
| 2014Q3 | -6.0 million USD | 9.4 million USD |
| 2014Q2 | -8.4 million USD | 7.8 million USD |
| 2014Q1 | -8.7 million USD | 8.0 million USD |
| 2013Q4 | 6.5 million USD | 24.3 million USD |
| 2013Q3 | -12.6 million USD | 4.5 million USD |
| 2013Q2 | -15.0 million USD | 1.0 million USD |
| 2013Q1 | -12.6 million USD | 821000 USD |
| 2012Q4 | -10.1 million USD | 2.2 million USD |
| 2012Q3 | -10.0 million USD | 1.7 million USD |
| 2012Q2 | -8.9 million USD | 1.8 million USD |
| 2012Q1 | -9.9 million USD | 1.8 million USD |
| 2011Q4 | -11.9 million USD | 757000 USD |
| 2011Q3 | -10.6 million USD | 1.4 million USD |
| 2011Q2 | -13.6 million USD | 1.1 million USD |
| 2011Q1 | -11.7 million USD | 763000 USD |
| 2010Q4 | -11.6 million USD | 1.1 million USD |
| 2010Q3 | -12.3 million USD | 394000 USD |
| 2010Q2 | -13.1 million USD | 462000 USD |
| 2010Q1 | -12.2 million USD | 621000 USD |
| 2009Q4 | -12.5 million USD | 1.0 million USD |
| 2009Q3 | -8.2 million USD | 5.5 million USD |
| 2009Q2 | 56.0 million USD | 71.9 million USD |
| 2009Q1 | -10.7 million USD | 3.1 million USD |
| 2008Q4 | -10.9 million USD | 3.2 million USD |
| 2008Q3 | -16.3 million USD | 3.1 million USD |
| 2008Q2 | -15.4 million USD | 3.1 million USD |
| 2008Q1 | -13.9 million USD | 3.1 million USD |
| 2007Q4 | -13.3 million USD | 3.1 million USD |
| 2007Q3 | -11.3 million USD | 4.1 million USD |
| 2007Q2 | -12.6 million USD | 3.2 million USD |
| 2007Q1 | -11.7 million USD | 3.2 million USD |
| 2006Q4 | -15.9 million USD | 155000 USD |
| 2006Q3 | -14.9 million USD | 106000 USD |
| 2006Q2 | -13.8 million USD | 1.4 million USD |
| 2006Q1 | -12.5 million USD | 1.4 million USD |
| 2005Q4 | -11.1 million USD | 2.1 million USD |
| 2005Q3 | -10.1 million USD | 1.9 million USD |
| 2005Q2 | -10.5 million USD | 2.3 million USD |
| 2005Q1 | -10.5 million USD | 2.6 million USD |
| 2004Q4 | -11.8 million USD | 2.2 million USD |
| 2004Q3 | -10.2 million USD | 2.4 million USD |
| 2004Q2 | -9.2 million USD | 2.9 million USD |
| 2004Q1 | -5.9 million USD | 5.9 million USD |
| 2003Q4 | -8.2 million USD | 2.6 million USD |
| 2003Q3 | -8.2 million USD | 2.6 million USD |
| 2003Q2 | -7.7 million USD | 2.6 million USD |
| 2003Q1 | -7.1 million USD | 2.7 million USD |
| 2002Q4 | ? USD | 11.4 million USD |
CYTK Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -526.2 million USD | 7.5 million USD |
| 2022 | -402.6 million USD | 94.6 million USD |
| 2021 | -242.4 million USD | 70.4 million USD |
| 2020 | -164.1 million USD | 55.8 million USD |
| 2019 | -149.1 million USD | 26.9 million USD |
| 2018 | -106.3 million USD | 31.5 million USD |
| 2017 | -127.8 million USD | 13.4 million USD |
| 2016 | 16.5 million USD | 106.4 million USD |
| 2015 | -37.5 million USD | 28.7 million USD |
| 2014 | -14.6 million USD | 46.9 million USD |
| 2013 | -33.7 million USD | 30.6 million USD |
| 2012 | -39.0 million USD | 7.6 million USD |
| 2011 | -47.9 million USD | 4.0 million USD |
| 2010 | -49.3 million USD | 2.6 million USD |
| 2009 | 24.5 million USD | 81.5 million USD |
| 2008 | -56.4 million USD | 12.4 million USD |
| 2007 | -48.9 million USD | 13.6 million USD |
| 2006 | -57.1 million USD | 3.1 million USD |
| 2005 | -42.3 million USD | 8.9 million USD |
| 2004 | -37.2 million USD | 13.4 million USD |
| 2003 | -32.7 million USD | 10.6 million USD |
| 2002 | -23.1 million USD | 11.4 million USD |
| 2001 | -15.9 million USD | 8.5 million USD |
| 2000 | -13.1 million USD | ? USD |
CYTK
Price: $63.37
52 week price:
Payout Ratio Range:
Earnings Per Share: -5.45 USD
P/E Ratio: -14.75
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 998300
Ebitda: -35.8 millionMarket Capitalization: 7.1 billion